The page cannot be displayed because you are using Internet Explorer version 8 or lower.

Please consider upgrading your browser here

We use cookies on this website. By using the website you accept our use of cookies. Accept

 
 
 
 

Investigator Initiated Clinical Trials

Grant capital: 
From DKK 5 to 20 million per project over a project period of 3-5-years
Total grant capital in 2018 is DKK 80 million

 

Application form:
Will be open from February 19, 2018

 

Application deadlines
June 13, 2018, 2pm
 

Decision announcements
Mid-December, 2018

 

The earliest project start date
January 1, 2019

(The grant cannot be activated until all approvals from the relevant public authorities have been obtained)

 

The latest project start date
November 30, 2019

 

 

This is a yearly recurring call.
The next application round is expected to open in February 2019.

Committee on Clinical and Translational Medicine

Lars Fugger, Jens Otto Lunde Jørgensen, Gedske Daugaard, Jan Gerstoft, Jørgen Frøkiær, Henrik Toft Sørensen, Lars Køber, Claus Nerlov

Link to committee

The call and application guidelines will be updated before the next application round opens!

PURPOSE

The purpose is to strengthen the opportunities to carry out larger clinical trials in Denmark that do not have commercial purpose. The ultimate objective is to improve the treatment of patients through new medicine and new technology and to ensure the highest quality in treatment.
 

ELIGIBILITY

Project:

  • The clinical trials must conform to good clinical practice guidelines (GCP).
  • Clinical relevance and scientific quality is imperative, and a detailed protocol including calculation of power, data management plan, and plan for statistical analysis of data must be included.
  • The project must be anchored at a hospital in Denmark and must be led by a specialist physician.
  • Any clinical trial that receives a grant from the Novo Nordisk Foundation must be registered at ClinicalTrials.gov or clinicaltrialsregister.eu (EudraCT).
  • When the clinical trial ends, the anonymized data must be made available to other researchers through public databases such as the Zenodo open data repository (CERN) or other equivalent databases.
  • An applicant can submit an application to the foundation before all legal approvals have been obtained, but the grant cannot be activated until all approvals from the relevant public authorities have been obtained.

Main applicant:

  • The main applicant (investigator) must be a specialist physician employed at the hospital where the project is anchored.
  • The main applicant must have documented experience in research leadership and well-documented research activities.

 

Postdocs and PhD students cannot be co-applicants.

FUNDING

The budget frame for each grant is from DKK 5 million to DKK 20 million over a period of 3–5 years. The grant capital in 2018 is DKK 80 million.

 

RESEARCH FIELDS

Applications may be submitted for most types of larger clinical trials that include patients and aim to improve existing treatment routines. Randomized controlled trials are preferred; however, nonrandomized trials are also accepted.

 

APPLICATION PROCESS

For the full description of eligibility and requirements for the application please thoroughly read: ”Information and guidelines for applicants – Investigator Initiated Clinical Trials 2018”.

The application must be submitted in English and completed using the internet-based application system.

 

Contact

Ursula Bach

Senior Administrator

Tlf.: +45 3527 6609

Email: urba@novo.dk